Medtronic PLC Market Cap ($109.30 Billion)
Market Cap & Net Worth: Medtronic PLC (MDT)
Medtronic PLC market cap. Medtronic PLC (NYSE:MDT) has a market capitalization of $109.30 Billion ($109.30 Billion) as of November 1, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #225 globally and #120 in its home market, demonstrating a -0.05% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medtronic PLC's stock price $96.54 by its total outstanding shares 1280045190 (1.28 Billion). Also see Medtronic PLC (MDT) cash conversion ratio for how efficiently the company converts equity into cash flow.
Medtronic PLC Market Cap History (2015–2026)
Medtronic PLC market cap history from 2015 to 2026. Data shows growth from $79.06 Billion to $123.58 Billion (4.51% CAGR). Check today's stock price for Medtronic PLC for real-time trading data and today's change.
Index Memberships
Medtronic PLC is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$61.47 Trillion | 0.24% | #95 of 503 |
|
S&P 100
OEX
|
$44.16 Trillion | 0.34% | #74 of 101 |
Weight: Medtronic PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Medtronic PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medtronic PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Medtronic PLC (MDT) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
3.40x
Medtronic PLC's market cap is 3.40 times its annual revenue
Latest Price to Earnings (P/E) Ratio
25.74x
Medtronic PLC's market cap is 25.74 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $86.65 Billion | $29.71 Billion | $4.03 Billion | 2.92x | 21.51x |
| 2018 | $99.81 Billion | $29.95 Billion | $3.10 Billion | 3.33x | 32.15x |
| 2019 | $127.09 Billion | $30.56 Billion | $4.63 Billion | 4.16x | 27.44x |
| 2020 | $134.34 Billion | $28.91 Billion | $4.79 Billion | 4.65x | 28.05x |
| 2021 | $121.19 Billion | $30.12 Billion | $3.61 Billion | 4.02x | 33.61x |
| 2022 | $93.86 Billion | $31.69 Billion | $5.04 Billion | 2.96x | 18.63x |
| 2023 | $102.85 Billion | $31.23 Billion | $3.76 Billion | 3.29x | 27.37x |
| 2024 | $102.25 Billion | $32.36 Billion | $3.68 Billion | 3.16x | 27.82x |
| 2025 | $122.96 Billion | $33.54 Billion | $4.66 Billion | 3.67x | 26.38x |
| 2026 | $123.58 Billion | $36.36 Billion | $4.80 Billion | 3.40x | 25.74x |
Competitor Companies of MDT by Market Capitalization
Companies near Medtronic PLC in the global market cap rankings as of November 1, 2026. Also see Medtronic PLC (MDT) total assets for a full breakdown of the balance sheet.
Key companies related to Medtronic PLC by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #322 globally with a market cap of $83.04 Billion USD ( €71.03 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #322 | Medtronic PLC | XETRA:2M6 | $83.04 Billion | €69.20 |
Market Capitalization of Medtronic PLC (2015–2026)
Market capitalization of Medtronic PLC from 2015 to today. Between 2015 and today, Medtronic PLC's market cap moved from $79.06 Billion to $ 123.58 Billion, with a yearly change of 4.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $123.58 Billion | +0.50% |
| 2025 | $122.96 Billion | +20.26% |
| 2024 | $102.25 Billion | -0.58% |
| 2023 | $102.85 Billion | +9.58% |
| 2022 | $93.86 Billion | -22.55% |
| 2021 | $121.19 Billion | -9.79% |
| 2020 | $134.34 Billion | +5.70% |
| 2019 | $127.09 Billion | +27.34% |
| 2018 | $99.81 Billion | +15.18% |
| 2017 | $86.65 Billion | +15.90% |
| 2016 | $74.77 Billion | -5.44% |
| 2015 | $79.06 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Medtronic PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $109.30 Billion USD |
| MoneyControl | $109.30 Billion USD |
| MarketWatch | $109.30 Billion USD |
| marketcap.company | $109.30 Billion USD |
| Reuters | $109.30 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardiovert… Read more